Andere talen Harrow, Inc.

Aandelen

HROW

US4158581094

Beurs gesloten - OTC Markets Andere beurzen 22:00:00 30-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
10,19 ^USD	-4,05%		-1,26%	-9,02%

11/04	HARROW, INC. : Craig-Hallum herhaalt koopadvies	ZM
22/03	HARROW, INC. : B. Riley herhaalt koopadvies voor het aandeel	ZM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Harrow Will Release First Quarter 2024 Financial Results After Market Close on May 13, 2024	26/04
Melt Pharmaceuticals Closes $24 Million Series B Preferred Stock Financing	03/04
Top Midday Decliners	20/03
Harrow Announces Fourth Quarter and Year-End 2023 Financial Results	20/03
Harrow, Inc. Provides Earnings Guidance for the Year 2024	20/03
Harrow Health Slumps 13% Premarket After Swinging to Core Net Loss in Q4 While Sales Jumped	20/03
North American Morning Briefing : Markets on Hold as Fed Decision Nears	20/03
Harrow : Q4-2023 Letter to Stockholders	19/03
Harrow, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	19/03
Harrow, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	19/03
Restore stock falls as weak tech trading drags down annual results	14/03
Harrow Will Release Fourth Quarter and Year-End 2023 Financial Results after Market Close on March 19, 2024	06/03
Harrow Announces New Appointments to its Board of Directors	30/01
Harrow, Inc. Announces Board of Director Appointments	29/01
Harrow Announces Availability of VEVYE 0.1%, the First and Only Cyclosporine-Based Product Indicated for Treating Both Signs and Symptoms of Dry Eye Disease	12/01
Harrow Health's Eye Treatment Drug Vevye Now Available in US	11/01
Harrow Announces Availability of Vevye® (Cyclosporine Ophthalmic Solution) 0.1%, the First and Only Cyclosporine-Based Product Indicated for Treating Both Signs and Symptoms of Dry Eye Disease	11/01
Harrow Partners with Leading Healthcare Market Access Technology Platforms	04/01
Melt Pharmaceuticals Provides Corporate Update	04/01
Harrow, Inc. Partners with Leading Healthcare Market Access Technology Platforms	03/01

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Harrow, Inc.

Aandelen

HROW

US4158581094

Andere talen

Filters